Calcium Channel Blockers - C alcium Antagonists Calcium Channel Blockers - C alcium Antagonists Selectively affect voltage- dependent calcium channels,

Slides:



Advertisements
Similar presentations
C ALCIUM C HANNEL B LOCKERS (CCB) Maureen McGuinness, RN (Karch, 2013)
Advertisements

Calcium Channel Blocking Drugs. Chemical TypeChemical NamesBrand Names PhenylalkylaminesverapamilCalan, Calna SR, Isoptin SR, Verelan BenzothiazepinesdiltiazemCardizem.
Cardiovascular pharmacology Chapter 32 Antianginal drugs China Medical University.
Part 6 Antianginal Drugs
Cardiac Arrhythmias.
Calcium antagonists (Summary) Dr Ivan Lambev
Clinical Toxicology & Pharmacology, Newcastle Mater Misericordiae Hospital Calcium channel blockers Professor Ian Whyte Hunter Area Toxicology Service.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 45 Calcium Channel Blockers.
Calcium Channel Blocking Drugs.
Calcium Antagonists Tatyana Voyno-Yasenetskaya
Cardiovascular Agents
Part 6 Antianginal Drugs Organic nitrates Organic nitrates  receptor blockers  receptor blockers Calcium channel blockers Calcium channel blockers.
Chapter 18 Agents that Dilate Blood Vessels. Copyright 2007 Thomson Delmar Learning, a division of Thomson Learning Inc. All rights reserved Coronary.
Cardio pharmacology Angina. angina Causes Atheroma Others: Aortic stenosis, aberrant coronary circulation, severe anaemia, arteritis Prevention Decrease.
1 ANGINA ANGINA MYOCARDIAL OXY. DEMAND >. OXY. SUPPLY. OXY. SUPPLY < SYMPTOMS – chest pain mostly relieved by taking rest, dyspnea, sweating, nausea..
Antianginal Drugs 抗心绞痛药 Antianginal Drugs. What’s Angina pectoris Cause and the classification of angina pectoris : – Atheromatous obstruction of the.
Diseases that Result from Abnormal Mitochondrial Function Lu Qiping April 15, 2011.
Part 4 Drugs for Treatment of Congestive Heart Failure.
1 Chapter 4 Circulatory System Agents. 2 3 Overview Cardiovascular disease is the first cause of death in developed countries. About 1/3-1/4 of 3000.
LEARNING ITS STRUCTURE AND HOW IT WORKS The Heart.
Excitable tissue- cardiac muscle Dr. Shafali Singh.
Chapter 31 Drugs for Treatment of Congestive Heart Failure.
Calcium Channel Blockers and Digitalis. Dig Ca Channel Blockers.
Agents that Dilate Coronary Blood Vessels.  Coronary artery disease (CAD) results from atherosclerosis  Clinical symptoms caused by  narrowing of the.
Antianginal Drugs Learning outcomes Recognize variables contributing to a balanced myocardial supply versus demand Expand on the drugs used to alleviate.
for more lecture notes Antianginal Agents Dr.Shadi-Sarahroodi Pharm.D & PhD Qom University of Medical sciences Iran PUBLISHED.
Antianginal Drugs Dr. Dennis Wolff Dept. Pharmacology, ext
Chapter 33 Agents Affecting the Autonomic Nervous System.
6/3/ CARDIOVASCULAR MEDICATIONS. FIRST DO NO HARM 6/3/ There are 5 rights to patient medication administration: 1. Right patient 2. Right.
Antianginal drugs Angina pectoris is the severe chest pain that occurs when coronary blood flow is inadequate to supply the oxygen required by the heart.
Electrophysiology of muscles. Skeletal Muscle Action Potential.
Part 5 Adrenoceptor Antagonists 1.  receptor antagonists 2.  receptor antagonists 3. ,  receptor antagonists.
Calcium. Role of Ca ++ in Cardiac and Smooth Muscle  Changes in intracellular Ca ++ regulate contraction through different mechanisms in cardiac and.
Cardiovascular Anatomy, Physiology and Pharmacology BS913 Lecture 10: Pharmacology cont., …
- Calcium channel blockers decrease blood pressure,cardiac workload, and myocardial oxygen consumption. - available in immediate-release and sustained-release.
Section III Circulation system.
Drugs for Congestive Heart Failure.
Chapter 34 Antihypertensive Drugs
Antianginal drugs Antidysrrhytmic drugs
ANTIHYPERTENSIVE DRUGS
Cardiac Arrhythmia.
CVS PHARMACOLOGY. Drugs to treat myocardial ischemia Etiology 1. Decrease in myocardial oxygen supply [determined by oxygen-carrying capacity of blood.
Calcium Channel Blockers. Smooth muscle: Most types of smooth muscle are dependent on transmembrane calcium influx for normal resting tone.
CCB in Management of Hypertension in Older Persons Presented by Mona Ahmed sherif Marwa Shaaban Shimaa Adel Ahmed Salma Sadek Alia khalid.
Calcium antagonists (Summary) Dr Ivan Lambev
Pharmacology PHL 101 Abdelkader Ashour, Ph.D. 10 th Lecture.
Effect of some adrenergic drugs and its blockers on the blood pressure.
Cardiovascular System & Blood Chapters 8 & 7. Cardiovascular system parts.
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc. Adrenoceptors  The adrenergic receptors are classified into Two categories:
Drugs acting on circulation system and blood / blood- forming organs.
Electrical Activity에 관한 공부
PHARMACOLOGY OF ANTI-ANGINAL DRUGS (ID#580) Dr. Mariam Yousif Pharmacology & Toxicology Dept. November 17 th, 2014.
Calcium Channel Blocking Drugs.
Ch 4. Voltage-gated Ca2+ channel
Drugs Affecting the Cardiovascular System
Anti-Anginal Drugs.
CALCIUM CHANNEL BLOCKERS/ANTAGONISTS
Anti Anginal Agents Pharmacology Week 10.
Anti-Anginal Drugs.
ACUTE SELF-POISONINGS BY VERAPAMIL
ANTI HYPERTENSIVE DRUGS
Drugs acting on cardiovascular system(CVS)
Adrenergic [ædrə‘nədʒik] agonists
Adrenergic antagonists
CALCIUM CHANNEL BLOCKERS/ANTAGONISTS
Antianginal Drugs.
Antiarrhythmic drugs [,æntiə'riðmik] 抗心律失常药
Chapter 21 Antiarrhythmic drugs [,æntiə'riðmik] 抗心律失常药
CARDIOVASCULAR AGENTS
Anti Anginal Agents Pharmacology Week 10.
Presentation transcript:

Calcium Channel Blockers - C alcium Antagonists Calcium Channel Blockers - C alcium Antagonists Selectively affect voltage- dependent calcium channels, inhibiting Ca 2+ entering into cells. Selectively affect voltage- dependent calcium channels, inhibiting Ca 2+ entering into cells.

Voltage-dependent calcium channels are classified into 6 subtypes : Voltage-dependent calcium channels are classified into 6 subtypes :

〔 Classification 〕 Selective calcium channel blockers: Selective calcium channel blockers: Ⅰ Phenylalkylamines: Verapamil Ⅰ Phenylalkylamines: Verapamil Ⅱ Dihydropyridines: Nifedipine Ⅱ Dihydropyridines: Nifedipine Ⅲ Benzothiazepines: Diltiazem Ⅲ Benzothiazepines: Diltiazem Non-selective calcium channel blockers: Non-selective calcium channel blockers: Ⅳ Flunarizine Ⅳ Flunarizine Ⅴ Prenylamine Ⅴ Prenylamine Ⅵ Others: Perhexiline Ⅵ Others: Perhexiline

Ⅰ Selective effects on L-type calcium channels , including 4 subcategories : Ⅰ Selective effects on L-type calcium channels , including 4 subcategories : Ⅰ aDihydropyridines: Ⅰ a Dihydropyridines: nifeidipine 、 nicardipine 、 nitrendipine (尼群地平)、 amlodipine (氨氯 地平)、 nimodipine Ⅰ bDiltiazem : Ⅰ b Diltiazem : diltiazem (地尔硫卓) 、 clentiazem (克仑硫卓) Ⅰ cPhenylalkylamines: Ⅰ c Phenylalkylamines: verapamil Ⅰ dTiapamil : Ⅰ d Tiapamil : tiapamil (噻烷丙胺)

(1) T type: Mibefradil (咪拉地尔) (2) N type: Conotoxin (竽螺毒素) (3) P type: Spider toxin (蜘蛛毒素) (1) T type: Mibefradil (咪拉地尔) (2) N type: Conotoxin (竽螺毒素) (3) P type: Spider toxin (蜘蛛毒素) Ⅱ Selective effects on other voltage- dependent calcium channels : Ⅲ Non-selective calcium channel blockers: Prenylamine (普尼拉明) Flunarizine (氟苯桂嗪)

Generations: Generations: First : Verapamil, Nifedipine, Diltiazem Second : Nimodipine 尼莫地平, Nicardipine 尼卡地平, Felodipine 非洛地平 Third : Pranidipine 普拉地平, Amlodipine 氨氯地平

L and T type are the main types in cardiovascular system, and L type is the most important one, which involves mainly in the contraction of cardiac and smooth muscle, sinuatrial node pacing 窦房结率, and atrioventricular conduction 房室间传导.

Extracellular The  1C subunit of the L-type Ca 2+ channel is the pore-forming subunit

The expression and function of the  1C subunit is modulated by other smaller subunits

Action Mode Resting State Open State Inactive State A I A A I I A: Activation Gate I: Inactivation Gate

VerapamilDiltiazemNifedipine Action State OpenOpenInactive Binding Site InsideInsideOutside Frequency- dependent YesYesNo

Cardiac cells rely on L-type Ca 2+ channels for the upstroke of the AP in slow response cells L-Type Slow Response Cells (SA node, AV node) Ca Calcium Channel Blockers

Actions  Heart negative inotropic effect 负性肌力作用 negative inotropic effect 负性肌力作用 negative frequency 负性频率 and negative conduction 负性传导作用: negative frequency 负性频率 and negative conduction 负性传导作用: obvious in sino-atrial node and atrioventricular node -rationale for treating supraventricular arrhythmia Actions  Heart negative inotropic effect 负性肌力作用 negative inotropic effect 负性肌力作用 negative frequency 负性频率 and negative conduction 负性传导作用: negative frequency 负性频率 and negative conduction 负性传导作用: obvious in sino-atrial node and atrioventricular node -rationale for treating supraventricular arrhythmia

 smooth muscle blood vessel : dilate A>V; obvious for spasmodic blood vessel; dilate coronary vessels 冠状血管 other smooth muscle: relax  anti-artherosclerosis 抗动脉粥样硬化作用 relieve vein wall injury caused by calcium overload relieve vein wall injury caused by calcium overload increase compliance of vessel wall increase compliance of vessel wall inhibit lipid peroxidation and protect endothelial cell inhibit lipid peroxidation and protect endothelial cell  smooth muscle blood vessel : dilate A>V; obvious for spasmodic blood vessel; dilate coronary vessels 冠状血管 other smooth muscle: relax  anti-artherosclerosis 抗动脉粥样硬化作用 relieve vein wall injury caused by calcium overload relieve vein wall injury caused by calcium overload increase compliance of vessel wall increase compliance of vessel wall inhibit lipid peroxidation and protect endothelial cell inhibit lipid peroxidation and protect endothelial cell

nifedipine increases intracellular cAMP, leading to a decrease of intracellular cholesterin nifedipine increases intracellular cAMP, leading to a decrease of intracellular cholesterin  RBC: relieve injury of RBC caused by calcium overload Inhibition of platelet activation Inhibition of platelet activation  Kidney: exclude sodium and diuresis nifedipine increases intracellular cAMP, leading to a decrease of intracellular cholesterin nifedipine increases intracellular cAMP, leading to a decrease of intracellular cholesterin  RBC: relieve injury of RBC caused by calcium overload Inhibition of platelet activation Inhibition of platelet activation  Kidney: exclude sodium and diuresis

Threapeutic uses angina: effective for all kinds angina: effective for all kinds arrhythmia : especially caused by supraventricular and after-depolarization triggered activity 后除极触发活动 arrhythmia : especially caused by supraventricular and after-depolarization triggered activity 后除极触发活动 hypertension hypertension cerebrovascular disease cerebrovascular disease peripheral angiospasm, prophylaxis of artherosclerosis, bronchial asthma, brow ache peripheral angiospasm, prophylaxis of artherosclerosis, bronchial asthma, brow ache Threapeutic uses angina: effective for all kinds angina: effective for all kinds arrhythmia : especially caused by supraventricular and after-depolarization triggered activity 后除极触发活动 arrhythmia : especially caused by supraventricular and after-depolarization triggered activity 后除极触发活动 hypertension hypertension cerebrovascular disease cerebrovascular disease peripheral angiospasm, prophylaxis of artherosclerosis, bronchial asthma, brow ache peripheral angiospasm, prophylaxis of artherosclerosis, bronchial asthma, brow ache